Rifaximin and IBS-D
Dr. Anthony Lembo of Beth Israel Deaconess Medical Center announced that he will present the results of TARGET 3 at...
Dr. Anthony Lembo of Beth Israel Deaconess Medical Center announced that he will present the results of TARGET 3 at...
This recently published research studied the benefit of eradicating h. pylori in patients that have been diagnosed with gastro-esophageal reflux...
A recent study done at the Boston Children’s Hospital shows that H2-receptor antagonists significantly increases the incidence of small intestinal...
This research focused on the benefits of using probiotic therapy for patients with chronic liver disease, small intestinal bacterial overgrowth...
The cause of autism has confounded medical science. Recently, research from Caltech has suggested that there may be a link...
Researchers at Lund University in Sweden have been studying whether leaky gut syndrome is a factor in multiple sclerosis (MS). ...
Interesting article appeared today on the Huffington Post that provides detailed advice on a homopathic cure for leaky gut. The...
Rifaximin is the antibiotic of choice for treating small intestinal bacterial overgrowth (SIBO). However, many patients prefer to avoid antibiotic...
Researchers at Case Western Reserve University School of Medicine have just released a study in PLOS Pathogens that concludes leaky...
Intestinal permeability or more commonly known as leaky guts syndrome, in irritable bowel syndrome (IBS) patients has been studied with...